Related Experiment Video
Updated: Nov 28, 2025
23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
8.2K
Parkinson's disease and translational research
Elisabeth Dinter1,2, Theodora Saridaki3, Leonie Diederichs3
1Department of Neurology, Technische Universität Dresden, Dresden, Germany.
Translational Neurodegeneration
|December 1, 2020
Summary
Parkinson's disease (PD) involves motor and non-motor symptoms, with key features including alpha-synuclein aggregates and dopaminergic neuron loss. Current research explores new therapeutic avenues based on these biological insights.
Area of Science:
- Neuroscience
- Neurology
- Pathology
Background:
- Parkinson's disease (PD) diagnosis traditionally relies on motor symptoms like bradykinesia, tremor, and rigidity, responsive to dopaminergic medication.
- Recent understanding highlights non-motor symptoms and prodromal states, indicating widespread nervous system pathology.
- Key pathological hallmarks include cytoplasmic aggregates of alpha-synuclein protein and degeneration of dopaminergic neurons.
Purpose of the Study:
- To review current concepts of major PD alterations: alpha-synuclein aggregation and dopaminergic neuron degeneration.
- To provide an overview of novel therapeutic approaches informed by recent literature and biological insights.
- To bridge the gap between basic research and effective therapeutic options for Parkinson's disease.
Main Methods:
- Literature review of current concepts and latest research in Parkinson's disease.
- Focus on cytoplasmic alpha-synuclein aggregates and dopaminergic neuron degeneration.
- Analysis of translational research advancements and their implications.
Main Results:
- Discussion of alpha-synuclein aggregation as a central pathological feature.
- Elaboration on the degeneration of dopaminergic neurons in Parkinson's disease.
- Identification of emerging therapeutic strategies based on these pathological insights.
Conclusions:
- Translational research has significantly advanced Parkinson's disease understanding.
- Despite progress, more effective therapies are needed, driven by deeper insights into basic biological phenomena.
- Future therapeutic development should leverage knowledge of alpha-synuclein and dopaminergic neurodegeneration.
Keywords:
AggresomeAutophagyDopamine deficiencyMedium spiny neuronsPre-formed fibrilsProtein aggregatesα-SynucleinMore Related Videos
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
6.3K
09:21Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
1.8K
Related Concept Videos
01:15Parkinson's Disease: Overview
1.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.3K
01:24Parkinson's Disease: Treatment
770
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
770
01:21EPS and iPS Cells in Disease Research
3.1K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.1K
01:37Neural Regulation
42.3K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.3K
01:29Translational Regulation
386
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
386